Exacerbation of erythropoietic protoporphyria by hyperthyroidism

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Minder, Elisabeth I ^a   Haldemann, Andreas R ^a   Schneider Yin, Xiaoye ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AUTOANTIGEN; BIOLOGICAL MARKER; IODIDE PEROXIDASE; IRON BINDING PROTEIN; PROTOPORPHYRIN; RADIOACTIVE IODINE; THYROID HORMONE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN; TPO PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; CASE REPORT; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DISEASE COURSE; ERYTHROCYTE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; LIVER DISEASE; MALE; METABOLISM; TIME; TREATMENT OUTCOME; COMPLICATION; LIVER DISEASES; PORPHYRIA, ERYTHROPOIETIC; TIME FACTOR;

ADULT; AUTOANTIGENS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ERYTHROCYTES; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; IODIDE PEROXIDASE; IODINE RADIOISOTOPES; IRON-BINDING PROTEINS; LIVER DISEASES; MALE; PORPHYRIA, ERYTHROPOIETIC; PROTOPORPHYRINS; THYROID HORMONES; TIME FACTORS; TRANSAMINASES; TREATMENT OUTCOME; BIOMARKERS;

EID: 84897924583     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9234-z     Document Type: Article

References (23)

1. Anderson K, Sassa S, Bishop D, Desnick R (2001) The porphyrias. In: Scriver CR, Beaudet al., Sly WS, Valle D (eds) Childs B, Kinzler KW, Vogelstein B, assoc. eds. The metabolic and molecular basis of inherited disease, 8th edn. New York: McGraw-Hill, 2991-3062
2. Barnes HD, Hurworth E, Millar JH (1968) Erythropoietic porphyrin hepatitis. J Clin Pathol 21:157-159
3. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H (1998) The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J 17:4291-4303
4. Beaver DC, Pemberton JD (1933) The pathologic anatomy of the liver in exophthalmic goiter. Ann Intern Med 7:687-708
5. Bonkovsky HL, Schned AR (1986) Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterology 90:191-201
6. Delaby C, Lyoumi S, Ducamp S, Martin-Schmitt C, Gouya L, Deybach JC, Beaumont C, Puy H (2009) Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) 55:45-52
7. Doss MO, Frank M (1989) Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem 22:223-229
8. Ford HC, Carter JM (1988) The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad Med J 64:735-742
9. Gouya L, Puy H, Robreau AM et al. (2004) Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet 114:256-262
10. Gross U, Frank M, Doss MO (1998) Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 14:52-57
11. Gurlek A, Cobankara V, Bayraktar M (1997) Liver tests in hyperthyroidism: effect of antithyroid therapy. J Clin Gastroenterol 24:180-183
12. Hollowell JG, Staehling NW, Flanders WD et al. (2002) Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-99
13. Holme SA, Anstey AV, Finlay AY, Elder GH, Badminton MN (2006) Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 155:574-581
14. Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN (2007) Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 110:4108-4110
15. Lyoumi S, Abitbol M, Andrieu V et al. (2007) Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Blood 109:811-818
16. Magnus IA, Jarrett A, Prankerd TA, Rimington C (1961) Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet 2:448-451
17. Minder EI, Gouya L, Schneider-Yin X, Deybach JC (2002) A genotype-phenotype correlation between null-Allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) 48:91-96
18. Onaga Y, Ido A, Uto H et al. (2004) Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria. Biochem Biophys Res Commun 321:851-858
19. Schneider-Yin X, Harms J, Minder EI (2009) Porphyria in Switzerland, 15 years experience. Swiss Med Wkly 139:198-206
20. Wahlin S (2010) Erythropoietic protoporphyria, clinical and epidemiological aspects. Thesis, Karolinska Institutet (http://diss.kib.ki.se/ 2010/978-91-7409-817-4/thesis.pdf, accessed 20. September 2010).
21. Whatley SD, Ducamp S, Gouya L et al. (2008) C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83:408-414
22. Yamada K, Nakamura Y, Sekiguchi T, Fueki R, Kobayashi S (1971) Erythropoietic protoporphyria associated with hyperthyroidism and jaundice. Naika 28:1171-1174
23. Zenke M, Muñoz A, Sap J, Vennström B, Beug H (1990) v-erbAoncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61:1035-1049